Back to search

Article

Modulation of CIP2A dimerization and protein stability via druggable pocket

2025-10-14

Abstract excerpt

Cancerous inhibitor of PP2A (CIP2A) supports malignant growth across several cancer types. CIP2A is also a synthetic lethal therapy target for BRCA-mutant cancers. In addition, CIP2A causes Alzheimer's disease (AD) phenotype in mice. However, it is not dispensable for normal development and growth. Therefore, CIP2A is very lucrative therapy target in cancer and AD. So far it has been unclear whether the CIP2A prot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
812a032d-8079-5ad6-afa0-08a2fc10d132
DOI
10.1101/2025.10.13.682046
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modulation of CIP2A dimerization and protein stability via druggable pocketDOI 10.1101/2025.10.13.682046
Select a neighboring publication to make it the new centre.